GENEVA, Sept. 18 -- MEIJI PHARMACEUTICAL UNIVERSITY filed a patent application (JP2026/007838) for “ANTISENSE OLIGONUCLEOTIDE TARGETING EXON 2 OF APOE GENE”. With publication no. WO/2026/186713, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....